黄嘌呤氧化酶
非布索坦
高尿酸血症
蛋白质数据库
化学
尿酸
自动停靠
对接(动物)
黄嘌呤
生物化学
药理学
黄嘌呤氧化酶抑制剂
氧化酶试验
酶
医学
基因
护理部
生物信息学
作者
Xuejie Wang,Zhijian Lin,Bing Zhang,Chunsheng Zhu,Niu Hongjuan,Yue Zhou,Anzheng Nie,Yu Wang
标识
DOI:10.4268/cjcmm20151922
摘要
Human xanthine oxidase is considered to be a target for therapy of hyperuricemia. Cichorium intybus is a Chinese plant medicine which widely used in Xinjiang against various diseases. In order to screen the inhibitors of xanthine oxidase from C. intybus and to explore main pharmacological actions of cichory a compound collection of C. intybus was built via consulting related references about chemical research on cichory. The three-dimensional crystal structure of xanthine oxidase (PDB code: 1N5X) from Protein Data Bank was downloaded.. Autodock 4.2 was employed to screen the inhibitors of xanthine oxidase from cichory 70 compounds were found to possess quite low binding free energy comparing with TEI (febuxostat). C. intybus contains constituents possessing potential inhibitive activity against xanthine oxidase. It can explain the main pharmacological actions of cichory which can significantly lower the level of serum uric acid.
科研通智能强力驱动
Strongly Powered by AbleSci AI